Type II diabetes is a chronic condition that results when the body’s insulin does not work effectively, it affects up to 6% of the US population, and has been growing in prevalence over the past decade. This issue covers all areas of noninsulin-dependent diabetes including insulin therapy and insulin strategies, hypertension management, glycemic management, multifactorial management, dyslipidemia, and novel pharmacologic agents.